Data as of Jan 30
| -0.48 / -2.70%|
The 7 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 19.00, with a high estimate of 24.00 and a low estimate of 15.00. The median estimate represents a +9.83% increase from the last price of 17.30.
The current consensus among 9 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.